Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Change in Acquisitions & Divestments: 2009-2012

Historic Change in Acquisitions & Divestments for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2012 value amounting to $74.8 million.

  • Lexicon Pharmaceuticals' Change in Acquisitions & Divestments rose 71.10% to $74.8 million in Q4 2012 from the same period last year, while for Dec 2012 it was $135.8 million, marking a year-over-year decrease of 23.09%. This contributed to the annual value of $314.4 million for FY2024, which is 80.82% up from last year.
  • As of Q4 2012, Lexicon Pharmaceuticals' Change in Acquisitions & Divestments stood at $74.8 million, which was up 539.91% from $11.7 million recorded in Q3 2012.
  • Lexicon Pharmaceuticals' 5-year Change in Acquisitions & Divestments high stood at $74.8 million for Q4 2012, and its period low was $100,000 during Q1 2009.
  • In the last 3 years, Lexicon Pharmaceuticals' Change in Acquisitions & Divestments had a median value of $28.0 million in 2011 and averaged $30.1 million.
  • As far as peak fluctuations go, Lexicon Pharmaceuticals' Change in Acquisitions & Divestments soared by 2,475.00% in 2010, and later plummeted by 76.30% in 2012.
  • Over the past 4 years, Lexicon Pharmaceuticals' Change in Acquisitions & Divestments (Quarterly) stood at $351,000 in 2009, then skyrocketed by 1,321.65% to $5.0 million in 2010, then skyrocketed by 775.85% to $43.7 million in 2011, then skyrocketed by 71.10% to $74.8 million in 2012.
  • Its Change in Acquisitions & Divestments was $74.8 million in Q4 2012, compared to $11.7 million in Q3 2012 and $26.9 million in Q2 2012.